Cargando…
Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
The coronavirus disease 2019 (COVID-19) pandemic has caused considerable socio-economic burden, which fueled the development of treatment strategies and vaccines at an unprecedented speed. However, our knowledge on disease recovery is sparse and concerns about long-term pulmonary impairments are inc...
Autores principales: | Kiener, Mirjam, Roldan, Nuria, Machahua, Carlos, Sengupta, Arunima, Geiser, Thomas, Guenat, Olivier Thierry, Funke-Chambour, Manuela, Hobi, Nina, Kruithof-de Julio, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139419/ https://www.ncbi.nlm.nih.gov/pubmed/34026781 http://dx.doi.org/10.3389/fmed.2021.644678 |
Ejemplares similares
-
A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System
por: Sengupta, Arunima, et al.
Publicado: (2022) -
Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go
Global?
por: Funke-Chambour, Manuela
Publicado: (2020) -
αAzithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
por: Krempaska, Kristina, et al.
Publicado: (2020) -
Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
por: Krempaska, Kristina, et al.
Publicado: (2020) -
Medium throughput breathing human primary cell alveolus-on-chip model
por: Stucki, Janick D., et al.
Publicado: (2018)